Pharmacologic Considerations in the Disposition of Antibodies and Antibody-Drug Conjugates in Preclinical Models and in Patients
about
Pharmacologic Considerations in the Disposition of Antibodies and Antibody-Drug Conjugates in Preclinical Models and in Patients
description
scientific article published on 01 January 2019
@en
name
Pharmacologic Considerations i ...... linical Models and in Patients
@en
type
label
Pharmacologic Considerations i ...... linical Models and in Patients
@en
prefLabel
Pharmacologic Considerations i ...... linical Models and in Patients
@en
P2093
P356
P1476
Pharmacologic Considerations i ...... linical Models and in Patients
@en
P2093
Allison N Schorzman
Andrew T Lucas
Joseph A Piscitelli
Juan F Razo
Ryan Robinson
William C Zamboni
P356
10.3390/ANTIB8010003
P577
2019-01-01T00:00:00Z